• Introduction to QIAGEN CLC Genomics Workbench & Getting Started

    Virtual - India , India

    In this training, we will introduce you to QIAGEN CLC Genomics Workbench, including a live demo of the basic features and main functionalities. During the training, we’ll cover: • A general overview of the Workbench user interface • Easy installation on Windows, Mac and Linux • Plugin installation, e.g., Biomedical Genomics Analysis plugin • Reference […]

  • New user training: Large dataset analysis and knowledge base queries using QIAGEN Ingenuity Pathway Analysis (IPA)

    Virtual - Americas - EST , United States

    Join us for a 120-minute training session for new users of QIAGEN IPA. In this training, you’ll learn how to: • Upload your dataset (RNA-seq, scRNA-seq, proteomics, metabolomics and more) and perform interactive core/pathway analysis in IPA • Understand the different result types produced (pathways, key regulators, impact on biological functions/diseases and more) • Compare […]

  • Circulating Tumor Cell Detection and Analysis to Support Malignancy Designation, Tumor-of-Origin Identification, and Treatment Selection

    Virtual - Americas - EST , United States

    Circulating tumor cells (CTCs) are cells that leave the primary tumor and are intravasated into the blood circulation system. A subset of those make it to other organs and are responsible for metastasis. iCellate’s CellMate platform is a CTC-based liquid biopsy for cancer cell enrichment, detection, and biomarker analysis via a simple blood draw. In this […]

  • Scale up NGS bioinformatics analysis throughput with QIAGEN CLC Genomics cloud computing

    Virtual - Americas - EST , United States

    Scale your NGS analysis to match your sequencing throughput using our QIAGEN CLC Genomics cloud solution. In this webinar, you’ll learn about the flexible and powerful setup for running your NGS sequence analyses on Amazon Web Services (AWS). You’ll learn how to use QIAGEN CLC Genomics Workbench to customize workflows and send analyses to AWS […]

  • QIAGEN Biomedical Knowledge Base: Data- and analytics-driven drug discovery

    Virtual - Americas - EST , United States

    Biomedical relationships knowledge is now required for innovative data- and analytics-driven drug discovery. It powers biomedical knowledge graph analysis, artificial intelligence (AI)-driven target identification and many more applications. In this one-hour training, you’ll get an introduction to QIAGEN Biomedical Knowledge Base. You’ll learn how to tackle applications you can’t achieve with the QIAGEN Ingenuity Pathway […]

  • Part 1: AI-Powered Hereditary Disease Diagnostics: Closing the Gap in Clinical Exome Completeness

    Virtual Global Event (Times shown in EST)

    Clinical exome sequencing (CES) is increasingly being adopted by small and mid-sized laboratories to diagnose genetic diseases, aid treatment decisions, and provide prognostic information. However, the exponential increase in genetic data generated from exome and genome panels poses significant workflow challenges. The ability to prioritize potentially pathogenic variants from large datasets and identify the few […]

  • Exploring pan-cancer immunomodulators for biomarker discovery and validation using TCGA and public single-cell data

    Virtual - Americas - EST , United States

    Cancer outcome is influenced by both the tumor microenvironment and host immune response. Using QIAGEN OmicSoft Studio to access public data from The Cancer Genome Atlas (TCGA) and our human Single Cell Lands collection, you’ll learn how to: • View host immune response clusters across TCGA samples • Identify differentially expressed immunomodulators across sample groups […]

  • Integrating deeply curated omics data with APIs for biomarkers and drug-target investigation

    Virtual - EMEA - CET

    This webinar is for data scientists and bioinformaticians working in biopharma who need extensive high-quality omics data for target discovery efforts. Learn how to programmatically discover, retrieve, filter, aggregate, and analyze omics data from QIAGEN’s extensive repositories of deeply-curated multi-omics data. Attendees will learn how to leverage extensive metadata to find and combine datasets of […]

  • RNA-seq data analysis and interpretation using QIAGEN CLC and QIAGEN IPA

    Virtual - Americas - EST , United States

    This 120-minute training will teach you how to easily analyze and interpret RNA-seq data using QIAGEN CLC Genomics Workbench software and QIAGEN Ingenuity Pathway Analysis (IPA). For RNA-seq data, you will learn how to: • Import FASTQ files, cell matrix files and metadata and how to download references • Map reads to a reference genome […]

  • A breakthrough for rare disease: Completing the Clinical exome gap!

    Virtual Global Event (Times shown in EST)

    In its latest release, QCI Interpret for Hereditary extends its market-leading content with further advancements in Artificial Intelligence (AI) for enhanced capabilities in clinical exome NGS testing. Now, with the addition of AI-derived literature references for rare disease genes, QCI Interpret provides complete exome coverage, on top of the existing unrivalled manually curated content and […]

  • Multi-omics (metabolomics, proteomics, transcriptomics) analysis using QIAGEN Ingenuity Pathway Analysis

    Virtual - Americas - EST , United States

    This 90-minute training session is about how QIAGEN Ingenuity Pathway Analysis (IPA) allows visualization of molecular intricacy and variations at multiple levels such as transcriptome, proteome, and metabolome. Through a series of brief technical vignettes, it is demonstrated how to: · Generate associations among molecular signatures obtained via integrating multi-omics data · Extract mechanisms from […]

  • What's new in QIAGEN IPA Fall Release 2023?

    Virtual - EMEA - CET

    Interested in learning about new features and functionalities that have been added to IPA lately? During this webinar, we will highlight the updates from the QIAGEN IPA Fall Release and from previous releases from this year. Topics, amongst others, will be • Newly added findings and pathways • Reactome pathways • Artificial intelligence approves to […]